203 related articles for article (PubMed ID: 28666888)
41. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades.
Park JH; Yoon J; Park B
Phytomedicine; 2016 Dec; 23(14):1716-1726. PubMed ID: 27912873
[TBL] [Abstract][Full Text] [Related]
42. Melittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model.
Qin G; Chen Y; Li H; Xu S; Li Y; Sun J; Rao W; Chen C; Du M; He K; Ye Y
Mol Med Rep; 2016 Jul; 14(1):57-68. PubMed ID: 27177128
[TBL] [Abstract][Full Text] [Related]
43. Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2.
Rho SB; Song YJ; Lim MC; Lee SH; Kim BR; Park SY
Cell Signal; 2012 Jan; 24(1):131-9. PubMed ID: 21893193
[TBL] [Abstract][Full Text] [Related]
44. 4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models.
Huang TF; Wang SW; Lai YW; Liu SC; Chen YJ; Hsueh TY; Lin CC; Lin CH; Chung CH
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163369
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of cell growth and potentiation of tumor necrosis factor-α (TNF-α)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells.
Min HY; Chung HJ; Kim EH; Kim S; Park EJ; Lee SK
Biochem Pharmacol; 2010 Nov; 80(9):1356-64. PubMed ID: 20674553
[TBL] [Abstract][Full Text] [Related]
46. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
47. Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling.
Wang H; Zhang C; Ning Z; Xu L; Zhu X; Meng Z
Int J Oncol; 2016 Mar; 48(3):1229-41. PubMed ID: 26782953
[TBL] [Abstract][Full Text] [Related]
48. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
49. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
50. Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio.
Wang Y; Wang B; Guerram M; Sun L; Shi W; Tian C; Zhu X; Jiang Z; Zhang L
Oncotarget; 2015 Oct; 6(30):29497-512. PubMed ID: 26470595
[TBL] [Abstract][Full Text] [Related]
51. Cellular repressor of E1A-stimulated genes regulates vascular endothelial cell migration by the ILK/AKT/mTOR/VEGF(165) signaling pathway.
Zhang H; Han Y; Tao J; Liu S; Yan C; Li S
Exp Cell Res; 2011 Dec; 317(20):2904-13. PubMed ID: 21939655
[TBL] [Abstract][Full Text] [Related]
52. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
Xie SR; Wang Y; Liu CW; Luo K; Cai YQ
Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854
[TBL] [Abstract][Full Text] [Related]
53. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
[TBL] [Abstract][Full Text] [Related]
54. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
[TBL] [Abstract][Full Text] [Related]
55. Autophagy promotes angiogenesis via AMPK/Akt/mTOR signaling during the recovery of heat-denatured endothelial cells.
Liang P; Jiang B; Li Y; Liu Z; Zhang P; Zhang M; Huang X; Xiao X
Cell Death Dis; 2018 Nov; 9(12):1152. PubMed ID: 30455420
[TBL] [Abstract][Full Text] [Related]
56. 15(S)-HETE-induced angiogenesis in adipose tissue is mediated through activation of PI3K/Akt/mTOR signaling pathway.
Soumya SJ; Binu S; Helen A; Reddanna P; Sudhakaran PR
Biochem Cell Biol; 2013 Dec; 91(6):498-505. PubMed ID: 24219292
[TBL] [Abstract][Full Text] [Related]
57. Genomic Identification of the TOR Signaling Pathway as a Target of the Plant Alkaloid Antofine in the Phytopathogen Fusarium graminearum.
Mogg C; Bonner C; Wang L; Schernthaner J; Smith M; Desveaux D; Subramaniam R
mBio; 2019 Jun; 10(3):. PubMed ID: 31186319
[TBL] [Abstract][Full Text] [Related]
58. Osteogenesis and angiogenesis induced by porous β-CaSiO(3)/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways.
Wang C; Lin K; Chang J; Sun J
Biomaterials; 2013 Jan; 34(1):64-77. PubMed ID: 23069715
[TBL] [Abstract][Full Text] [Related]
59. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
60. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]